Key Takeaways
- • Apax Partners LLP is acquiring two pharmaceutical packaging businesses from German company Gerresheimer AG for €1.5 billion ($1.7 billion), with legal counsel provided by Sullivan & Cromwell.
- • The transaction targets expansion of the acquired packing companies in the U.S. market, positioning the businesses for growth in North American pharmaceutical packaging.
- • Sullivan & Cromwell's involvement as legal advisor underscores the complexity and scale of the cross-border private equity transaction in the healthcare packaging sector.
Summary
Apax Partners LLP, a leading private equity firm, is acquiring two pharmaceutical packaging businesses from Gerresheimer AG, a German healthcare packaging manufacturer, for €1.5 billion (approximately $1.7 billion). The transaction was announced on July 29, 2026, according to filings and company statements.
The deal represents a strategic move by Apax to expand its portfolio in the pharmaceutical packaging sector, with a specific focus on strengthening these businesses' presence and capabilities in the U.S. market. Gerresheimer, a established player in healthcare packaging solutions, is divesting these two operations as part of its broader portfolio optimization strategy.
Sullivan & Cromwell, a prominent international law firm, is providing legal counsel for the transaction, indicating the deal's sophistication and the need for specialized expertise in cross-border M&A involving healthcare-adjacent assets. The involvement of a top-tier legal advisor reflects the complexity of regulatory compliance, due diligence, and structuring required for such transactions in the pharmaceutical packaging space.
The acquisition aligns with broader industry trends where private equity firms are consolidating fragmented packaging markets and pursuing operational improvements and geographic expansion to drive value creation across portfolio companies.
The deal represents a strategic move by Apax to expand its portfolio in the pharmaceutical packaging sector, with a specific focus on strengthening these businesses' presence and capabilities in the U.S. market. Gerresheimer, a established player in healthcare packaging solutions, is divesting these two operations as part of its broader portfolio optimization strategy.
Sullivan & Cromwell, a prominent international law firm, is providing legal counsel for the transaction, indicating the deal's sophistication and the need for specialized expertise in cross-border M&A involving healthcare-adjacent assets. The involvement of a top-tier legal advisor reflects the complexity of regulatory compliance, due diligence, and structuring required for such transactions in the pharmaceutical packaging space.
The acquisition aligns with broader industry trends where private equity firms are consolidating fragmented packaging markets and pursuing operational improvements and geographic expansion to drive value creation across portfolio companies.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.